BLRX
BioLineRX
BLRX
BLRX
26 hedge funds and large institutions have $1.97M invested in BioLineRX in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
32% less capital invested
Capital invested by funds: $2.91M → $1.97M (-$940K)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
26
Holding in Top 10
–
Calls
$222K
Puts
$174K
Top Buyers
| 1 | +$339K | |
| 2 | +$134K | |
| 3 | +$21.7K | |
| 4 |
HF
HRT Financial
New York
|
+$21K |
| 5 |
GVAG
Great Valley Advisor Group
Wilmington,
Delaware
|
+$20K |
Top Sellers
| 1 | -$2.02M | |
| 2 | -$107K | |
| 3 | -$48.6K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$21.4K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$17.6K |